Previous 10 | Next 10 |
home / stock / cvalf / cvalf news
2023-10-20 08:31:49 ET More on Covalon Technologies Covalon Technologies Ltd. 2023 Q3 - Results - Earnings Call Presentation Financial information for Covalon Technologies For further details see: Covalon announces issuance of deferred share units
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today is pleased to announce that the Company's Board of Directors has approved the grant of an aggregate of 295,000 deferred stock units (the "DSUs") to certain of its dire...
Visit Covalon at booth 715 at the AVA Conference and Exhibit to discover true compassionate vascular access solutions Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), a leader in advanced medical technologies, today announced ...
Discover Novel Compassionate Care Solutions at Booth 1835, McCormick Place Convention Center Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), a leader in advanced medical technologies, today announced its participation in the ...
2023-09-26 07:18:18 ET More on Covalon Technologies Ltd. Financial information for Covalon Technologies Ltd. Covalon Technologies Ltd. 2023 Q3 - Results - Earnings Call Presentation For further details see: Covalon Technologies appoints chair Boloor as its interi...
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that its Board of Directors (the “Board”) has appointed Amir Boloor, Chair of the Company’s Board, as Interim Chief Executive Officer (&...
Registration now open: Beyond the vein, see central vascular access through the eyes of the patient Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), a leader in advanced medical technologies, proudly announces the opening of registration for a unique, pa...
Visit Covalon at booth 425 at the Annual Association of Pediatric Hematology/Oncology Nurses Conference and Exhibit in Cleveland, Ohio to discover compassionate infection prevention technology designed for children Covalon Technologies Ltd. (the “Company” or “Covalo...
2023-08-16 14:45:15 ET More on Covalon Technologies Covalon Technologies rises on strong quarterly results For further details see: Covalon Technologies GAAP EPS of -C$0.02, revenue of C$6.3M
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its third quarter fiscal 2023 results. Brian Pedlar, Covalon’s President and CEO, said, “I am pleased to announce another strong financial ...
News, Short Squeeze, Breakout and More Instantly...
Recent changes and effective execution pave the way for strong Q2 results Q2 EBITDA of $1.7 million, Adjusted EBITDA of $2.5 million, and EPS of $0.06 Q2 year-on-year Revenue growth of 16%, focus area of US Product segment grew 54% Q2 Gross Margin increased to 63%, the h...
Faraday Future Intelligent Electric Inc. (FFIE) is expected to report for Q1 2024 D-Market Electronic Services & Trading (HEPS) is expected to report for Q1 2024 Christian Dior SE ADR (CHDRY) is expected to report for Q1 2024 Check-Cap Ltd. (CHEK) is expected to report $-0.17 for ...
Covalon Technologies Ltd. (CVALF) is expected to report for Q2 2024